Search

Vaibhav M Varkhedkar

from Chalfont, PA
Age ~53
Get Report
Also known as:
Vaibhav R
Phone and address:
309 Hamlet Dr, Chalfont, PA 18914
(215) 712-2569
Related to:
Ritvik V Varkhedkar, 22
Connected to:
Marianne M Varkiani, 32Glen M Varkoly, 48Svetlana Varkonyi, 43Enoch Varkpah, 36Leon Varlack, 73Pearl I Varlack, 90Alexander V Varlakhanov, 51Stephanie A Varlan, 53Jacob Varland, 37Joel N Varland, 65

Vaibhav Varkhedkar Phones & Addresses

  • 309 Hamlet Dr, Chalfont, PA 18914 (215) 712-2569
  • 7406 Encampment Rd, Lansdale, PA 19446 (267) 421-5090
  • Durham, NC
  • 7655 Palmilla Dr, San Diego, CA 92122
  • Mountain View, CA
  • Sunnyvale, CA
  • Buck, PA
  • Roxbury Crossing, MA
  • Somerville, MA
  • Waltham, MA
  • 309 Hamlet Dr, Chalfont, PA 18914 (267) 421-5090

Work

Company: Thomson reuters May 2014 Position: Contractor (temporary), ip and science

Education

School / High School: Duke University, The Fuqua School of Business- Durham, NC 2007 Specialities: Master of Business Administration

Resumes

Resumes

Vaibhav Varkhedkar Photo 1

Principal, Brandimpact

View page
Location:
400 Connell Dr, Berkeley Heights, NJ 07922
Industry:
Management Consulting
Work:
Iqvia
Principal, Brandimpact
Symphony Health Solutions Jun 2016 - Oct 2018
Principal, Commercial Effectiveness
Axtria - Ingenious Insights 2014 - Jun 2016
Associate Director
Ims Health 2013 - 2014
Engagement Manager, Us Oncology
Medimix International Jan 2012 - Jun 2013
Vice President, Analytics
Education:
Duke University 2007
Master of Business Administration, Masters Duke University - the Fuqua School of Business 2005 - 2007
Master of Business Administration, Masters, Finance University of Rhode Island 1993 - 1995
Master of Science, Masters, Chemistry University of Bombay May 1993
Bachelors, Bachelor of Arts University of Mumbai 1988 - 1993
Bachelors, Bachelor of Pharmacy, Pharmacy S.i.e.s. College of Science, Arts and Commerce 1986 - 1988
I.e.s. English Medium School 1979 - 1986
Skills:
Market Research
Competitive Analysis
Segmentation
Oncology
Data Analysis
Strategy
Pharmaceutical Industry
Marketing Strategy
Analytics
Competitive Intelligence
Business Strategy
Consulting
Quantitative Research
Primary Research
Commercialization
Biotechnology
Market Analysis
Cross Functional Team Leadership
Marketing Research
Business Development
Data Analytics
Business Analytics
Life Sciences
Management
Analysis
Customer Insight
Drug Discovery
Customer Relationship Management
Decision Analysis
Promotional Response Modeling
Management Consulting
Sas
Product Development
Business Analysis
Analytical Skills
Marketing Mix
Advanced Statistical Analyses
Product Launch
Pharmaceutics
Crm
Product Management
Strategic Planning
Leadership
Project Management
Business Intelligence
Forecasting
Healthcare
Author
Interests:
Science and Technology
Arts and Culture
Health
Languages:
Marathi
Hindi
English
Vaibhav Varkhedkar Photo 2

Vaibhav Varkhedkar

View page
Vaibhav Varkhedkar Photo 3

Vaibhav Varkhedkar

View page
Work:
Thomson Reuters

May 2014 to 2000
Contractor (Temporary), IP and Science
US Oncology
Plymouth Meeting, PA
Jul 2013 to Apr 2014
Engagement Manager
Medimix International
Jersey City, NJ
Jan 2012 to Jun 2013
Vice President, Analytics
ORC International
New York, NY
2009 to 2011
Vice President, Custom Market Research
TNS Healthcare
Horsham, PA
2007 to 2008
Research Manager
Ariad

1996 to 2005
Research Associate - Associate Scientist (Biotech Research and Development)
Education:
Duke University, The Fuqua School of Business
Durham, NC
2007
Master of Business Administration
University of Rhode Island, College of Pharmacy
Kingston, RI
1995
Master of Science in Medicinal Chemistry
University of Bombay, Prin. K.M.K. College of Pharmacy
Mumbai, Maharashtra
1993
Bachelor of Pharmaceutical Sciences

Publications

Us Patents

Substituted Alkyl Piperazine Derivatives

View page
US Patent:
6451798, Sep 17, 2002
Filed:
Feb 22, 2001
Appl. No.:
09/792167
Inventors:
Vaibhav Varkhedkar - Sunnyvale CA
Venkata P. Palle - Mountain View CA
Jeff Zablocki - Mountain View CA
Elfatih Elzein - Fremont CA
Brent K. Blackburn - Los Altos CA
Assignee:
CV Therapeutics, Inc. - Palo Alto CA
International Classification:
A61K 31495
US Classification:
51425212, 544400
Abstract:
Novel compounds of the general formula: and pharmaceutically acceptable acid addition salts thereof, wherein the compounds are useful in therapy to protect skeletal muscles against damage resulting from trauma or to protect skeletal muscles subsequent to muscle or systemic diseases such as intermittent claudication, to treat shock conditions, to preserve donor tissue and organs used in transplants, in the treatment of cardiovascular diseases including atrial and ventricular arrhythmias, Prinzmetals (variant) angina, stable angina, and exercise induced angina, congestive heart disease, and myocardial infarction.

Partial Or Full A1Agonists-N-6 Heterocyclic 5€²-Thio Substituted Adenosine Derivatives

View page
US Patent:
6605597, Aug 12, 2003
Filed:
Dec 3, 1999
Appl. No.:
09/454136
Inventors:
Jeff A. Zablocki - Mountain View CA
Venkata P. Palle - Mountain View CA
Vaibhav Varkhedkar - Sunnyvale CA
Luiz Belardinelli - Menlo Park CA
Assignee:
CV Therapeutics, Inc. - Palo Alto CA
International Classification:
A61K 5170
US Classification:
514 46, 536 273
Abstract:
N heterocyclic 5â modified adenosine derivatives that are adenosine A receptor partial or full agonists, and as such, are useful for modifying cardiac activity, modifying adipocyte function, treating central nervous system disorders, and treating diabetic disorders and obesity in mammals, and especially in humans.

A2B Adenosine Receptor Antagonists

View page
US Patent:
6770651, Aug 3, 2004
Filed:
Jun 27, 2002
Appl. No.:
10/184494
Inventors:
Venkata Palle - Sunnyvale CA, 94087
Vaibhav Varkhedkar - Mountain View CA, 94040
Jeff Zablocki - Mountain View CA, 94040
Dengming Xiao - Longmont CO, 80501
International Classification:
C07D47316
US Classification:
51426337, 51426338, 5142634, 544276, 544277
Abstract:
Disclosed are novel A adenosine receptor antagonists of Formula I: A compound of the formula: wherein: R is optionally substituted alkyl or a group âYâZ, in which Y is a covalent bond or optionally substituted alkylene, and Z is optionally substituted cycloalkyl, optionally substituted aryl, optionally substituted heteroaryl, optionally substituted heterocyclyl, optionally substituted alkenyl or optionally substituted alkynyl, with the proviso that when Y is a covalent bond Z cannot be alkenyl or alkynyl; and X is oxygen, sulfur, or NHâ, or a pharmaceutically acceptable salt, ester, or prodrug thereof. The compounds are particularly useful for treating asthma and diabetic retinopathy.

A2B Adenosine Receptor Antagonists

View page
US Patent:
6825349, Nov 30, 2004
Filed:
Nov 8, 2002
Appl. No.:
10/290921
Inventors:
Rao Kalla - Mountain View CA
Thao Perry - San Jose CA
Elfatih Elzein - Fremont CA
Vaibhav Varkhedkar - San Diego CA
Xiaofen Li - Palo Alto CA
Prabha Ibrahim - Mountain View CA
Venkata Palle - Gurgaon, IN
Dengming Xiao - Longmont CO
Jeff Zablocki - Mountain View CA
Assignee:
CV Therapeutics Inc. - Palo Alto CA
International Classification:
C07D47312
US Classification:
544267, 544269, 544270, 544271, 544272
Abstract:
Disclosed are novel A adenosine receptor antagonists compounds having the structure of Formula I or Formula II: The compounds are particularly useful for treating asthma, inflammatory gastrointestinal tract disorders, cardiovascular diseases, neurological disorders, and diseases related to undesirable angiogenesis.

Partial And Full Agonists Of A1 Adenosine Receptors

View page
US Patent:
6946449, Sep 20, 2005
Filed:
Jul 11, 2002
Appl. No.:
10/194335
Inventors:
Elfatih Elzein - Fremont CA, US
Prabha Ibrahim - Mountain View CA, US
Venkata Palle - Sunnyvale CA, US
Vaibhav Varkhedkar - Mountain View CA, US
Jeff Zablocki - Mountain View CA, US
Assignee:
CV Therapeutics, Inc. - Palo Alto CA
International Classification:
A61K031/70
C07H019/16
C07H019/167
US Classification:
514 46, 5142631, 514266, 536 273, 536 2763, 544264
Abstract:
Disclosed are novel compounds that are partial and full Aadenosine receptor agonists, useful for treating various disease states, in particular tachycardia and atrial flutter, angina, and myocardial infarction.

A2B Adenosine Receptor Antagonists

View page
US Patent:
6977300, Dec 20, 2005
Filed:
May 6, 2003
Appl. No.:
10/431167
Inventors:
Rao Kalla - Mountain View CA, US
Thao Perry - San Jose CA, US
Elfaith Elzein - Fremont CA, US
Vaibhav Varkhedkar - San Diego CA, US
Xiaofen Li - Palo Alto CA, US
Prabha Ibrahim - Mountain View CA, US
Venkata Palle - Gurgaon, IN
Dengming Xiao - Longmont CO, US
Jeff Zablocki - Mountain View CA, US
Assignee:
CV Therapeutics, Inc. - Palo Alto CA
International Classification:
C07D473/04
A61K031/522
A61P035/00
A61P011/06
A61P025/16
US Classification:
544269, 544267, 544270, 544271, 544272
Abstract:
Disclosed are novel Aadenosine receptor antagonists having the structure of Formula I or Formula II: The compounds are particularly useful for treating asthma, inflammatory gastrointestinal tract disorders, cardiovascular diseases, neurological disorders, and diseases related to undesirable angiogenesis.

Aadenosine Receptor Antagonists

View page
US Patent:
7105665, Sep 12, 2006
Filed:
Sep 23, 2004
Appl. No.:
10/947708
Inventors:
Rao Kalla - Cupertino CA, US
Thao Perry - San Jose CA, US
Elfatih Elzein - Fremont CA, US
Vaibhav Varkhedkar - San Diego CA, US
Xiaofen Li - Palo Alto CA, US
Prabha Ibrahim - Mountain View CA, US
Venkata Palle - Gurgaon, IN
Dengming Xiao - Longmont CO, US
Jeff Zablocki - Mountain View CA, US
Assignee:
CV Therapeutics, Inc. - Palo Alto CA
International Classification:
C07D 473/04
C07D 473/06
C07D 473/08
A61K 31/522
A61P 9/10
US Classification:
544270, 544267, 544269, 544271, 544272
Abstract:
Disclosed are methods for making novel Aadenosine receptor antagonists having the structure of formula I or Formula II:.

Partial And Full Agonists Of A1 Adenosine Receptors

View page
US Patent:
7157440, Jan 2, 2007
Filed:
May 27, 2004
Appl. No.:
10/855471
Inventors:
Elfatih Elzein - Fremont CA, US
Prabha Ibrahim - Mountain View CA, US
Venkata Palle - Gurgaon, IN
Vaibhav Varkhedkar - San Diego CA, US
Jeff Zablocki - Mountain View CA, US
Assignee:
CV Therapeutics, Inc. - Palo Alto CA
International Classification:
A01N 43/04
A61K 31/70
C07H 19/00
C07H 19/22
US Classification:
514 46, 514 45, 536 271, 536 2713, 536 272, 536 2721, 536 273, 536 2762
Abstract:
Disclosed are novel compounds that are partial and full Aadenosine receptor agonists, useful for treating various disease states, in particular tachycardia and atrial flutter, angina, and myocardial infarction.
Control profile
Vaibhav M Varkhedkar from Chalfont, PA, age ~53 Get Report